Antonian L - Search Results

1

Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416.

Ye C, Sweeny D, Sukbuntherng J, Zhang Q, Tan W, Wong S, Madan A, Ogilvie B, Parkinson A, Antonian L. Ye C, et al. Among authors: antonian l. Toxicol In Vitro. 2006 Mar;20(2):154-62. doi: 10.1016/j.tiv.2005.06.047. Toxicol In Vitro. 2006. PMID: 16321501 Review.

2

Simultaneous determination of Z-SU5416 and its interconvertible geometric E-isomer in rat plasma by LC/MS/MS.

Zhao Y, Sukbuntherng J, Antonian L. Zhao Y, et al. Among authors: antonian l. J Pharm Biomed Anal. 2004 May 28;35(3):513-22. doi: 10.1016/j.jpba.2003.08.017. J Pharm Biomed Anal. 2004. PMID: 15137976

3

Biotransformation of the anti-angiogenic compound SU5416.

Antonian L, Zhang H, Yang C, Wagner G, Shawver LK, Shet M, Ogilvie B, Madan A, Parkinson A. Antonian L, et al. Drug Metab Dispos. 2000 Dec;28(12):1505-12. Drug Metab Dispos. 2000. PMID: 11095590

4

Pharmacokinetics and interspecies scaling of a novel VEGF receptor inhibitor, SU5416.

Sukbuntherng J, Cropp G, Hannah A, Wagner GS, Shawver LK, Antonian L. Sukbuntherng J, et al. Among authors: antonian l. J Pharm Pharmacol. 2001 Dec;53(12):1629-36. doi: 10.1211/0022357011778232. J Pharm Pharmacol. 2001. PMID: 11804393

5

Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species.

Haznedar JO, Patyna S, Bello CL, Peng GW, Speed W, Yu X, Zhang Q, Sukbuntherng J, Sweeny DJ, Antonian L, Wu EY. Haznedar JO, et al. Among authors: antonian l. Cancer Chemother Pharmacol. 2009 Sep;64(4):691-706. doi: 10.1007/s00280-008-0917-1. Epub 2009 Jan 25. Cancer Chemother Pharmacol. 2009. PMID: 19169880

6

Application of LC/MS/MS in the quantitation of SU101 and SU0020 uptake by 3T3/PDGFr cells.

Zhang Q, Pang WL, Chen H, Cherrington J, Lipson K, Antonian L, Shawver LK. Zhang Q, et al. Among authors: antonian l. J Pharm Biomed Anal. 2002 May 15;28(3-4):701-9. doi: 10.1016/s0731-7085(01)00654-9. J Pharm Biomed Anal. 2002. PMID: 12008150

7

Simultaneous determination of SU5416 and its phase I and phase II metabolites in rat and dog plasma by LC/MS/MS.

Zhao Y, Yang CY, Haznedar J, Antonian L. Zhao Y, et al. Among authors: antonian l. J Pharm Biomed Anal. 2001 Jul;25(5-6):821-32. doi: 10.1016/s0731-7085(01)00341-7. J Pharm Biomed Anal. 2001. PMID: 11377065

8

Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes.

Madan A, Graham RA, Carroll KM, Mudra DR, Burton LA, Krueger LA, Downey AD, Czerwinski M, Forster J, Ribadeneira MD, Gan LS, LeCluyse EL, Zech K, Robertson P Jr, Koch P, Antonian L, Wagner G, Yu L, Parkinson A. Madan A, et al. Among authors: antonian l. Drug Metab Dispos. 2003 Apr;31(4):421-31. doi: 10.1124/dmd.31.4.421. Drug Metab Dispos. 2003. PMID: 12642468

9

An automated method for the determination of subnanogram concentrations of eprinomectin in bovine plasma.

Antonian L, DeMontigny P, Wislocki PG. Antonian L, et al. J Pharm Biomed Anal. 1998 Apr;16(8):1363-71. doi: 10.1016/s0731-7085(97)00183-0. J Pharm Biomed Anal. 1998. PMID: 9777610

10

Automation of steroid radioimmunoassays using a robotics workstation.

Antonian L, Iacolina MD, Proulx RR. Antonian L, et al. Clin Lab Sci. 1995 Mar-Apr;8(2):117-20. Clin Lab Sci. 1995. PMID: 10150469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page